From: Linear headache: clinical characteristics of eight new cases
 | Migraine (Murtaza et al. 2009)a | Linear headache |
---|---|---|
Mean age at onset (years) | 22 ± 15 | 41.8 ± 14.12 |
Age range at onset (years) | 6–65 | 20–73 |
Female/Male ratio | 141/65Â =Â 2.16:1 | 12/8Â =Â 1.5:1 |
Severity of pain | Moderate to severe (Kelman, 2006) | Moderate to severe |
Pain character | ||
Pressure-like | 23.8Â % | 4:20Â =Â 20Â % |
Distending/stretching | 9.7Â % | 10:20Â =Â 50Â % |
Throbbing/pulsating | 31.6Â % | 6:20Â =Â 30Â % |
Accompaniments | ||
Nausea | 57.8Â % | 8:20Â =Â 40Â % |
Vomiting | 32Â % | 4:20Â =Â 20Â % |
Diziness | 17Â % | 4:20Â =Â 20Â % |
Photophobia | 51.9Â % | 1:20Â =Â 5Â % |
Phonophobia | 58.7Â % | 1:20Â =Â 5Â % |
Average episode duration (h) | ||
Less than 2Â h | 23.4Â % | 7:20Â =Â 35Â % |
Half day (2–10 h) | 41.4 % | 7:20 = 35 % |
1 day (10–24 h) | 14.1 % | 6:20 = 30 % |
More than 1Â day (>24Â h) | 21.1Â % | 7:20Â =Â 35Â % |
Triggered by | ||
Noise, bright night, depression, fatigue and resting after physical activity | Yes | Yes |
Stress, staying up late | Yes | Yes |
Menstruation | Common (Miziara et al. 2003) | Common |
Treatment requirement | Approximate half patients (MacGregor et al. 2003) | Most cases |
Treatment | ||
Response to flunarizine | Most patients (Luo et al. 2012) | Common |
Response to sodium valproate | Most patients (MacGregor et al. 2003), and recommendation with level A evidence (Silberstein et al. 2012) | Common |
Response to carbamazepine | Possibably effective in some patients with no new evidence (Silberstein et al. 2012) | No response |
Response to oxcarbazepine | No response (Silberstein et al. 2008) | No response |